FIGSHIGH SIGNALFINANCIAL10-K

FIGS delivered exceptional financial performance with revenue growing 60% to $419.6M and operating income surging 1,584% to $38.1M, signaling a major operational turnaround.

This represents a dramatic improvement in operational efficiency and profitability, suggesting FIGS has successfully scaled its business model and improved cost management. The massive operating leverage demonstrates the company's ability to convert revenue growth into bottom-line profits, which should significantly improve investor confidence in the business model.

Comparing 2026-02-26 vs 2025-02-27View on EDGAR →
FINANCIAL ANALYSIS

FIGS showed remarkable financial improvement with revenue jumping 60% to $419.6M while operating income exploded from $2.3M to $38.1M, indicating exceptional operational leverage and margin expansion. The company maintained a strong balance sheet with total assets growing 14% to $580M and stockholders' equity increasing 16% to $437.5M, while reducing capital expenditures by 52% and dramatically cutting share buybacks from $45.5M to $2.7M. Despite a 25% decline in operating cash flow to $61.2M, the overall picture signals a company that has achieved significant scale and profitability improvements, transitioning from a marginal to a highly profitable business model.

FINANCIAL STATEMENT CHANGES
Operating Income
P&L
+1584.2%
$2.3M$38.1M

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

Net Income
P&L
+1159.2%
$2.7M$34.3M

Net income grew 1159.2% — bottom-line growth signals improving overall business health.

Share Buybacks
Cash Flow
-94.1%
$45.5M$2.7M

Buyback activity reduced 94.1% — capital being redeployed elsewhere or cash conservation underway.

Revenue
P&L
+59.5%
$263.1M$419.6M

Strong top-line growth of 59.5% — accelerating demand or successful expansion into new markets.

Capital Expenditure
Cash Flow
-52%
$17.0M$8.2M

Capex reduced 52% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Operating Cash Flow
Cash Flow
-24.6%
$81.2M$61.2M

Operating cash flow softened — monitor whether temporary working capital timing or structural deterioration.

Accounts Receivable
Balance Sheet
-19.3%
$6.6M$5.4M

Receivables declined — improved collection efficiency or conservative revenue recognition.

Current Assets
Balance Sheet
+16.9%
$382.8M$447.3M

Current assets grew 16.9% — improving short-term liquidity or inventory/receivables build.

Stockholders Equity
Balance Sheet
+16%
$377.1M$437.5M

Equity base grew 16% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Total Assets
Balance Sheet
+13.8%
$509.8M$580.0M

Asset base grew 13.8% — expansion through organic growth, acquisitions, or capital deployment.

LANGUAGE CHANGES
NEW — 2026-02-26
PRIOR — 2025-02-27
ADDED
As of February 13, 2026, there were 158,093,481 shares of the Registrant s Class A common stock, par value $0.0001, outstanding and 8,283,641 shares of the Registrant s Class B common stock, $0.0001 par value per share outstanding.
Our ability to source and distribute our products, including our ability to do so profitably, is impacted by global trade policy.
By elevating scrubs and creating premium products for healthcare professionals that support them on and off-shift, we revolutionized the large and fragmented healthcare apparel market, branded a previously unbranded industry and de-commoditized a previously commoditized product.
Our differentiated approach to creating authentic and meaningful relationships with our community, including through impact and advocacy, has allowed us to build a growing base of approximately 2.9 million active customers as of December 31, 2025 who are passionate about and loyal to our brand.
Our Market Opportunity Demand for Healthcare Professionals is Projected to Grow.
+7 more — sign up free →
REMOVED
As of February 14, 2025, there were 154,236,572 shares of the Registrant s Class A common stock, par value $0.0001, outstanding and 8,283,641 shares of the Registrant s Class B common stock, $0.0001 par value per share outstanding.
We plan to expand into additional international markets over time, which will expose us to new and significant risks.
By elevating scrubs and creating premium products for healthcare professionals, we revolutionized the large and fragmented healthcare apparel market, branded a previously unbranded industry and de-commoditized a previously commoditized product.
Our differentiated approach to creating authentic and meaningful relationships with our community has allowed us to build a growing base of approximately 2.7 million active customers as of December 31, 2024 who are passionate about and loyal to our brand.
In line with our purpose-driven mission, giving back is ingrained in everything we do at FIGS and has been from the beginning.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →